Lantheus Medical Imaging Inc - Company Profile

Powered by

All the data and insights you need on Lantheus Medical Imaging Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Lantheus Medical Imaging Inc Strategy Report

  • Understand Lantheus Medical Imaging Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Lantheus Medical Imaging Inc: Segment Analysis

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Business Description

Lantheus Medical Imaging Inc (Lantheus Medical) is a medical imaging company that focuses on the development, manufacture and commercialization of medical imaging agents and products. The company offers commercial products including ultrasound contrast agent and medical radiopharmaceuticals in a range of imaging modalities.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

R&D Overview

Lantheus Medical Imaging Inc (Lantheus Medical) is a medical imaging company that focuses on the development, manufacture and commercialization of medical imaging agents and products. The company offers commercial products including ultrasound contrast agent and medical radiopharmaceuticals in a range of imaging modalities. Its products include DEFINITY, TechneLite, Xenon_133, Neurolite, Thallium-201, Cardiolite and Gallium-67 . Its product pipeline include 1095, and LMI 1195. The company offers its products to nuclear physicians, internal medicine physicians, radiologists, technologists and sonographers, integrated delivery networks, hospitals, clinics and group practices. The company’s key product, DEFINITY is an ultrasound contrast imaging agent indicated for use in patients with suboptimal echocardiograms. It is used to improve the view of left ventricle of the heart during echocardiography. TechneLite is a Technetium (Tc-99m) generator, a radioactive isotope that can be attached to several imaging agents including Cardiolite and Neurolite used in nuclear medicine imaging procedures. Xenon- 133 gas is an inhaled radiopharmaceutical imaging agent used to assess pulmonary function and for imaging lungs. Lantheus Medical’s other commercial products include Neurolite, a technetium-labeled single photon emission computed tomography imaging agent used to identify the area where blood flow is blocked or reduced due to stroke in the brain; Thallium-201, an injectable radiopharmaceutical imaging agent used in myocardial perfusion imaging to detect cardiovascular disease; Cardiolite, an injectable, technetium-labeled imaging agent used in myocardial perfusion imaging procedures for the assessment of blood flow to the muscle of the heart using single photon emission computed tomography; Gallium-67, an injectable radiopharmaceutical imaging agent used to detect acute inflammatory lesions and various malignancies including lymphomas, Hodgkin’s disease and bronchogenic carcinomas. Its product pipeline 1095, commonly known as I-131-1095, targets PSMA and is intended to provide a dosage of beta radiation directly to prostate cancer cells with little to no effect on the healthy tissues around them, and LMI 1195, a cardiac neuronal agent that allows the identification of patients who are at risk of sudden cardiac death. The company distributes its products through its sales team in the US and Canada. It has manufacturing facilities in North Billerica, Massachusetts. The company through its subsidiaries operates in the US, Canada, Puerto Rico, England and Wales and Ireland.

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer